Milton S. Hershey Medical Center
pennstatehealth.orgLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
486
Active
82
Phase 3
36
Total enrollment
2,782,052
Pipeline matrix
Showing 36 of 36 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| CNS Stimulant | — | — | — | — | — | 2 | |
| Bupivacaine | — | — | — | — | 2 | ||
| Travesol 10% | — | — | — | — | — | 1 | |
| Exparel | — | — | — | — | — | 1 | |
| Shampoo and saline | — | — | — | — | — | 1 | |
| Saline and Listerine | — | — | — | — | — | 1 | |
| Shampoo and Listerine | — | — | — | — | — | 1 | |
| Saline and Saline | — | — | — | — | — | 1 | |
| Cyclophosphamide | — | — | — | — | 5 | ||
| Eflornithine | — | — | — | — | — | 2 | |
| Vincristine | — | — | — | — | — | 2 | |
| Etoposide | — | — | — | — | 2 | ||
| Methotrexate | — | — | — | — | 2 | ||
| Temozolomide | — | — | — | — | — | 2 | |
| Topotecan | — | — | — | — | — | 1 | |
| Doxorubicin | — | — | — | — | — | 1 | |
| Ifosfamide | — | — | — | — | — | 1 | |
| Cisplatin | — | — | — | — | — | 1 | |
| Silmitasertib | — | — | — | — | — | 1 | |
| Irinotecan | — | — | — | — | — | 1 | |
| INM176 | — | — | — | — | — | 1 | |
| Semaglutide Pen Injector | — | — | — | — | — | 1 | |
| AMXT 1501 Dicaprate | — | — | — | — | — | 1 | |
| CBG/CBD Oil | — | — | — | — | — | 1 | |
| Saline | — | — | — | — | 4 | ||
| Angiotensin- | — | — | — | — | — | 2 | |
| Vitamin B6 25 MG | — | — | — | — | — | 1 | |
| Vitamin B6 50 MG | — | — | — | — | — | 1 | |
| Vitamin B6 100 MG | — | — | — | — | — | 1 | |
| Estradiol | — | — | — | — | — | 1 | |
| ketorolac tromethamine | — | — | — | — | — | 1 | |
| saline control | — | — | — | — | — | 1 | |
| NJOY e-cigarette | — | — | — | — | — | 1 | |
| Trazodone | — | — | — | — | 2 | ||
| salivary RNA collection | — | — | — | — | — | 1 | |
| Buccal swab saliva for further genetic testing | — | — | — | — | — | 1 |
Next readouts
- 2025-06-30
- 2026-05-30
- 2026-06
- 2026-11
- 2026-11-01
- 2026-12
- 2026-12
- 2026-12-10
- 2027-05-01
- 2027-10-01
Top conditions
- Asthma20
- Breast Cancer15
- Obesity9
- Pain8
- Tobacco Dependence8
- Endometriosis7
- Physical Activity7
- Autism Spectrum Disorder7
Frequently asked questions about Milton S. Hershey Medical Center
- How many clinical trials does Milton S. Hershey Medical Center have on ClinicalTrials.gov?
- Milton S. Hershey Medical Center is listed as the lead sponsor on 486 clinical trials in ClinicalTrials.gov, 82 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Milton S. Hershey Medical Center's trials are in Phase 3?
- 36 of Milton S. Hershey Medical Center's trials are in Phase 3, spread across 36 active drug programs.
- What therapeutic areas does Milton S. Hershey Medical Center focus on?
- Milton S. Hershey Medical Center's most-studied conditions on ClinicalTrials.gov are Asthma, Breast Cancer, Obesity, Pain, Tobacco Dependence.
- When are Milton S. Hershey Medical Center's next clinical trial readouts?
- Milton S. Hershey Medical Center has 10 upcoming primary-completion readouts tracked here; the soonest is “Electronic Cigarette-derived Oxidants and Cardiopulmonary Effects”, expected around 2025-06-30.